Serendipitous discovery of aryl boronic acids as beta-lactamase inhibitors.
Yang, S.W., Pan, J., Root, Y., Scapin, G., Xiao, L., Su, J.(2020) Bioorg Med Chem Lett 30: 126795-126795
- PubMed: 31759850 
- DOI: https://doi.org/10.1016/j.bmcl.2019.126795
- Primary Citation of Related Structures:  
6UQS, 6UQT, 6UQU, 6UR3 - PubMed Abstract: 
High throughput screening for β-lactamase inhibitors afforded biphenyl hits such as 1. Hit confirmation and X-ray soaking experiments with Pseudomonas Aeruginosa AmpC enzyme led to the identification of an aryl boronic acid-serine complex 4, which was formed from phenyl boronic acid 8 (an impurity in compound 1) and ethylene glycol (the cryoprotectant in the soaking experiment).
Organizational Affiliation: 
Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ 07033, USA.